Inhaled corticosteroid + long-acting beta-agonist (ICS+LABA) combination therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Inhaled corticosteroid + long-acting beta-agonist (ICS+LABA) combination therapy, covering 2025-03-11 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma [Phase 4]